RESIDEO TECHNOLOGIES, INC. REZI
NYSE Price as of Nov 6, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jul 4, 2026
Market cap
$2.94B
P/E (GAAP, TTM)
7.69
P/E (operating)
6.14
Dividend yield
0.0%
Revenue growth YoY
2.0%
EPS growth YoY
109.1%
ROIC
8.8%
Piotroski F-score
4
Three ways to read the P/E
P/E (GAAP, TTM)
7.69
Net income of the last 4 quarters. Includes investment gains and one-time items.
P/E (GAAP, annual)
—
Net income of the latest fiscal year. Includes investment gains and one-time items.
P/E (operating)
6.14
After-tax operating income only: the core business.
P/E (excl. gains)
—
Net income after removing identified investment and asset-sale gains.
How it has changed
Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.
| Metric | 2026Q3 | 2026Q2 | Change QoQ | 2025Q3 | Change YoY |
|---|---|---|---|---|---|
| Revenue growth YoY (qtr) | 2.0% | 8.0% | -6.1 pts | 22.3% | -20.3 pts |
| EPS growth YoY (qtr) | 109.1% | 950.0% | -840.9 pts | -3,042.1% | +3,151.2 pts |
| Revenue growth (TTM) | 3.4% | 8.1% | -4.7 pts | 20.0% | -16.6 pts |
| EPS growth (TTM) | 146.0% | -1,293.3% | +1,439.3 pts | -564.4% | +710.4 pts |
| P/E (GAAP, TTM) | 7.20 | — | — | — | — |
| P/E (operating) | 5.64 | 9.67 | -4.03 | — | — |
| P/E (excl. gains) | — | — | — | — | — |
| P/B | 0.93 | 1.59 | -0.66 | — | — |
| ROIC | 8.8% | 8.8% | 0.0 pts | 7.3% | +1.5 pts |
| Net margin | -7.1% | -7.1% | 0.0 pts | 1.7% | -8.8 pts |
| Dividend yield | 0.0% | 0.0% | 0.0 pts | — | — |
| EPS (TTM) | 2.52 | -3.58 | +170.4% | -5.48 | +146.0% |
| Price | $18.15 | $31.12 | -41.7% | — | — |
History by quarter-end
Reported quarters
| Quarter ended | Revenue | QoQ | YoY | EPS | QoQ | YoY | Net margin |
|---|---|---|---|---|---|---|---|
| Jul 4, 2026 | $1.98B | 3.6% | 2.0% | 0.51 | 200.0% | 109.1% | 4.9% |
| Apr 4, 2026 | $1.91B | 0.9% | 8.0% | 0.17 | -82.8% | 950.0% | 2.0% |
| Dec 31, 2025 * | $1.90B | 1.7% | 2.0% | 0.99 | 16.5% | 1,550.0% | 7.2% |
| Sep 27, 2025 | $1.86B | -4.1% | 2.0% | 0.85 | 115.2% | 1,114.3% | 8.4% |
| Jun 28, 2025 | $1.94B | 9.8% | 22.3% | -5.59 | -27,850.0% | -3,042.1% | -42.5% |
| Mar 29, 2025 | $1.77B | -4.7% | 19.1% | -0.02 | -133.3% | -106.9% | 0.3% |
| Dec 31, 2024 * | $1.86B | 1.6% | 20.9% | 0.06 | -14.3% | -89.3% | 1.2% |
| Sep 28, 2024 | $1.83B | 15.0% | 17.6% | 0.07 | -63.2% | -50.0% | 1.1% |
| Jun 29, 2024 | $1.59B | 6.9% | -0.8% | 0.19 | -34.5% | -44.1% | 1.9% |
| Mar 30, 2024 | $1.49B | -3.3% | -4.1% | 0.29 | -48.2% | -23.7% | 2.9% |
| Dec 31, 2023 * | $1.54B | -1.1% | -1.5% | 0.56 | 300.0% | 107.4% | 5.3% |
| Sep 30, 2023 | $1.55B | -3.0% | -4.0% | 0.14 | -58.8% | -66.7% | 1.4% |
* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.
All figures
Price & size
| Fiscal year end | Dec 31, 2025 | End date of the latest annual (10-K) report used. |
|---|---|---|
| Price date | Nov 6, 2026 | Date of the latest closing price used. |
| Price | $19.39 | Latest closing price. |
| Market cap | $2.94B | Price × shares outstanding. |
| Enterprise value | $5.47B | Market cap + debt − cash: the price of the whole business. |
| Shares | 151.85M | Shares outstanding used for market cap. |
Valuation
| P/E (GAAP, annual) | — | Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative. |
|---|---|---|
| P/E (GAAP, TTM) | 7.69 | Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items. |
| P/E (operating) | 6.14 | Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items. |
| P/E (operating, TTM) | 7.07 | Market cap ÷ after-tax operating income of the last four quarters. |
| P/E (excl. gains) | — | Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified. |
| PEG | — | P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap. |
| PEG (TTM) | 0.05 | TTM P/E ÷ TTM EPS growth rate (in %). |
| Earnings yield | -17.9% | Net income ÷ market cap. The inverse of the P/E. |
| Earnings yield (TTM) | 13.0% | TTM EPS ÷ price. |
| P/B | 1.01 | Market cap ÷ shareholders' equity. Blank when equity is negative. |
| P/S | 0.39 | Market cap ÷ revenue of the latest fiscal year. |
| P/S (TTM) | 0.38 | Market cap ÷ revenue of the last four quarters. |
| P/FCF | — | Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative. |
| EV/EBITDA | 6.82 | Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels. |
| EV/EBIT | 9.01 | Enterprise value ÷ operating income. |
| EV/Sales | 0.73 | Enterprise value ÷ revenue. |
| Book value / share | 19.21 | Shareholders' equity ÷ shares. |
| FCF yield | -42.6% | Free cash flow ÷ market cap. |
Operating vs. one-time earnings
| Operating EPS | 3.16 | After-tax operating income per share (latest fiscal year). |
|---|---|---|
| Investment gains | — | Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified. |
| Asset-sale gains | — | One-time gains or losses from selling property, assets or businesses. Blank = none identified. |
| Non-operating income | -$1.06B | Pre-tax income minus operating income: interest, investment results and one-time items combined. |
| Gains as % of net income | 0.0% | Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains. |
Latest quarter & trailing 12 months
| Latest quarter | Jul 4, 2026 | End date of the most recent reported quarter. |
|---|---|---|
| Revenue (qtr) | $1.98B | Revenue of the latest reported quarter. |
| Net income (qtr) | $97.00M | Net income of the latest reported quarter. |
| EPS (qtr) | 0.51 | Diluted EPS of the latest reported quarter. |
| Revenue growth YoY (qtr) | 2.0% | Latest quarter revenue vs the same quarter a year earlier. |
| Revenue growth QoQ (qtr) | 3.6% | Latest quarter revenue vs the previous quarter. |
| EPS growth YoY (qtr) | 109.1% | Latest quarter EPS vs the same quarter a year earlier. |
| EPS growth QoQ (qtr) | 200.0% | Latest quarter EPS vs the previous quarter. |
| Net income growth YoY (qtr) | 111.8% | Latest quarter net income vs the same quarter a year earlier. |
| Net income growth QoQ (qtr) | 155.3% | Latest quarter net income vs the previous quarter. |
| Gross margin (qtr) | 30.0% | Gross profit ÷ revenue in the latest quarter. |
| Operating margin (qtr) | 6.6% | Operating income ÷ revenue in the latest quarter. |
| Net margin (qtr) | 4.9% | Net income ÷ revenue in the latest quarter. |
| Revenue (TTM) | $7.65B | Revenue of the last four quarters. |
| Net income (TTM) | $427.00M | Net income of the last four quarters. |
| EPS (TTM) | 2.52 | Sum of the last four quarters of diluted EPS. |
| Revenue growth (TTM) | 3.4% | Last four quarters of revenue vs the four quarters before. |
| EPS growth (TTM) | 146.0% | Last four quarters of EPS vs the four quarters before. |
| Net income growth (TTM) | 155.0% | Last four quarters of net income vs the four quarters before. |
Dividends & shareholder returns
| Dividend yield | 0.0% | Dividends paid per share over the last 12 months ÷ price. |
|---|---|---|
| Dividend / share (TTM) | — | Dividends per share paid over the last 12 months. |
| Payout ratio | — | Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings. |
| FCF payout ratio | — | Dividends ÷ free cash flow. |
| Dividend growth (1y) | — | Dividends per share vs the same 12-month window a year earlier. |
| Dividend CAGR (3y) | — | Annualised dividend growth over 3 years. |
| Dividend CAGR (5y) | — | Annualised dividend growth over 5 years. |
| Payments (12m) | — | Number of dividend payments in the last 12 months. |
| Last ex-dividend date | — | Most recent ex-dividend date. |
| Buyback yield | 0.0% | Share repurchases ÷ market cap. |
| Shareholder yield | 0.0% | Dividend yield + buyback yield. |
Profitability
| Gross margin | 29.4% | Gross profit ÷ revenue (latest fiscal year). |
|---|---|---|
| EBITDA margin | 10.7% | EBITDA ÷ revenue. |
| Operating margin | 8.1% | Operating income ÷ revenue. |
| Net margin | -7.1% | Net income ÷ revenue. |
| FCF margin | -16.8% | Free cash flow ÷ revenue. |
| ROE | -18.1% | Return on equity: net income ÷ shareholders' equity. Blank when equity is negative. |
| ROA | -6.2% | Return on assets: net income ÷ total assets. |
| ROIC | 8.8% | Return on invested capital: after-tax operating income ÷ (equity + debt − cash). |
Growth (annual)
| Revenue growth (annual) | 10.5% | Latest fiscal year revenue vs the year before. |
|---|---|---|
| Net income growth (annual) | -554.3% | Latest fiscal year net income vs the year before. |
| EPS growth (annual) | -718.0% | Latest fiscal year diluted EPS vs the year before. |
| Revenue CAGR (3y) | 5.5% | Annualised revenue growth over 3 fiscal years. |
| EPS CAGR (3y) | — | Annualised EPS growth over 3 fiscal years. |
Financial health
| Current ratio | 1.91 | Current assets ÷ current liabilities. Above 1 means short-term bills are covered. |
|---|---|---|
| Quick ratio | 1.14 | (Current assets − inventory) ÷ current liabilities. |
| Cash ratio | 0.38 | Cash ÷ current liabilities. |
| Debt / equity | 1.09 | Total debt ÷ shareholders' equity. Blank when equity is negative. |
| Debt / assets | 0.38 | Total debt ÷ total assets. |
| Debt / EBITDA | 3.97 | Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt. |
| Net debt / EBITDA | 3.15 | (Debt − cash) ÷ EBITDA. Negative means more cash than debt. |
| Interest coverage | 4.50 | Operating income ÷ interest expense. |
Earnings quality
| FCF conversion | — | Free cash flow ÷ net income. Above 100% means profits turn into real cash. |
|---|---|---|
| Accruals ratio | 7.2% | (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings. |
| Stock comp % revenue | 0.8% | Share-based compensation ÷ revenue. |
| R&D % revenue | 2.2% | Research & development spending ÷ revenue. |
| SG&A % revenue | 16.9% | Selling, general & administrative expense ÷ revenue. |
| Tax rate used | 21.0% | Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown). |
Efficiency
| Asset turnover | 0.89 | Revenue ÷ total assets. |
|---|---|---|
| Days sales outstanding | — | Average days to collect payment from customers. |
| Days inventory | 94 | Average days inventory is held. |
| Days payables | 78 | Average days to pay suppliers. |
Trading & momentum
| 52-week high | $42.95 | Highest price in the last 52 weeks. |
|---|---|---|
| 52-week low | $15.90 | Lowest price in the last 52 weeks. |
| From 52-week high | -54.9% | How far below the 52-week high the price is (0% = at the high). |
| Above 52-week low | 21.9% | How far above the 52-week low the price is. |
| Avg volume (30d) | 917.89K | Average shares traded per day over the last 30 days. |
| Avg $ volume (30d) | $16.27M | Average dollars traded per day over the last 30 days: a liquidity measure. |
Scores
| Piotroski F-score | 4 | Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail. |
|---|---|---|
| Altman Z-score | 1.73 | Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers. |
Reported figures (latest fiscal year)
| Revenue | $7.47B | Revenue of the latest fiscal year. |
|---|---|---|
| Net income | -$527.00M | Net income of the latest fiscal year. |
| Diluted EPS | -3.77 | Diluted earnings per share of the latest fiscal year. |
| EBITDA | $802.00M | Operating income + depreciation & amortization. |
| Free cash flow | -$1.25B | Operating cash flow − capital spending. |
| Total debt | $3.19B | Long-term plus current debt. |
| Cash | $661.00M | Cash and equivalents. |
| Equity | $2.92B | Shareholders' equity. |
| Total assets | $8.43B | Total assets. |